130 related articles for article (PubMed ID: 7960961)
21. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.
Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH
Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of soluble form of HLA class I molecule in Japanese patients with pancreatic cancer.
Shimura T; Tsutsumi S; Hosouchi Y; Kojima T; Kon Y; Yonezu M; Kuwano H
Hum Immunol; 2001 Jun; 62(6):615-9. PubMed ID: 11390036
[TBL] [Abstract][Full Text] [Related]
23. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004.
Rebmann V; Lemaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
Hum Immunol; 2005 Aug; 66(8):853-63. PubMed ID: 16216668
[TBL] [Abstract][Full Text] [Related]
24. [Method of detection of soluble HLA-I and soluble HLA-I level alteration in storage blood].
Lan JC; Wu T; Zhou HY; Zhang YZ; Wei YM; Lai ZF; Cao Q; Yang QK; Wu DL; Liu Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):363-7. PubMed ID: 15228668
[TBL] [Abstract][Full Text] [Related]
25. Increased level of soluble HLA class I antigens in systemic lupus erythematosus: correlation with anti-DNA antibodies and leukopenia.
Kippner L; Klint C; Sturfelt G; Bengtsson AA; Eriksson H; Truedsson L
J Autoimmun; 2001 Jun; 16(4):471-8. PubMed ID: 11437496
[TBL] [Abstract][Full Text] [Related]
26. Comparative reactivity of different HLA-G monoclonal antibodies to soluble HLA-G molecules.
Fournel S; Huc X; Aguerre-Girr M; Solier C; Legros M; Praud-Brethenou C; Moussa M; Chaouat G; Berrebi A; Bensussan A; Lenfant F; Le Bouteiller P
Tissue Antigens; 2000 Jun; 55(6):510-8. PubMed ID: 10902607
[TBL] [Abstract][Full Text] [Related]
27. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.
Fainardi E; Rizzo R; Melchiorri L; Castellazzi M; Paolino E; Tola MR; Granieri E; Baricordi OR
Mult Scler; 2006 Feb; 12(1):2-12. PubMed ID: 16459714
[TBL] [Abstract][Full Text] [Related]
28. Soluble HLA in saliva of patients with autoimmune rheumatic diseases.
Adamashvili I; Pressly T; Gebel H; Milford E; Wolf R; Mancini M; Sittg K; Ghali GE; Hall V; McDonald JC
Rheumatol Int; 2002 Jun; 22(2):71-6. PubMed ID: 12070679
[TBL] [Abstract][Full Text] [Related]
29. Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
Ciprandi G; Colombo BM; Contini P; Cagnati P; Pistorio A; Puppo F; Murdaca G
Allergy; 2008 Oct; 63(10):1335-8. PubMed ID: 18782112
[TBL] [Abstract][Full Text] [Related]
30. Immunogenicity of the soluble isoforms of HLA-G.
Hunt JS; Pace JL; Morales PJ; Ober C
Mol Hum Reprod; 2003 Nov; 9(11):729-35. PubMed ID: 14561816
[TBL] [Abstract][Full Text] [Related]
31. Increased soluble serum HLA class I antigens in patients with lymphoma.
Nocito M; Montalbán C; González-Porque P; Villar LM
Hum Immunol; 1997 Dec; 58(2):106-11. PubMed ID: 9475339
[TBL] [Abstract][Full Text] [Related]
32. Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage.
Fainardi E; Rizzo R; Lupato A; Ramponi V; De Santis G; Garofano F; Stignani M; Tamborino C; Castellazzi M; Casetta I; Baricordi OR
Acta Neurochir Suppl; 2010; 106():141-5. PubMed ID: 19812937
[TBL] [Abstract][Full Text] [Related]
33. Soluble HLA class I and class II antigens in patients with multiple sclerosis.
Ott M; Seidl C; Westhoff U; Stecker K; Seifried E; Fischer PA; Grosse-Wilde H
Tissue Antigens; 1998 Mar; 51(3):301-4. PubMed ID: 9550332
[TBL] [Abstract][Full Text] [Related]
34. Soluble histocompatibility class I antigens and beta 2-microglobulin in pregnant females and cord blood samples.
Inostroza J; Ferrada J; Navarrete C; Sorensen RU
Hum Immunol; 1997 Apr; 54(1):63-8. PubMed ID: 9154459
[TBL] [Abstract][Full Text] [Related]
35. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease.
Borghi A; Fogli E; Stignani M; Melchiorri L; Altieri E; Baricordi O; Rizzo R; Virgili A
Arch Dermatol Res; 2008 Nov; 300(10):551-9. PubMed ID: 18797896
[TBL] [Abstract][Full Text] [Related]
36. Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay.
Doxiadis I; Westhoff U; Grosse-Wilde H
Blut; 1989 Nov; 59(5):449-54. PubMed ID: 2684299
[TBL] [Abstract][Full Text] [Related]
37. HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy.
Hackmon R; Hallak M; Krup M; Weitzman D; Sheiner E; Kaplan B; Weinstein Y
Fetal Diagn Ther; 2004; 19(5):404-9. PubMed ID: 15305096
[TBL] [Abstract][Full Text] [Related]
38. Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response.
Park CW; Song HC; Shin YS; Ahn SJ; Kim YS; Kim SY; Choi EJ; Chang YS; Bang BK
Nephron; 1998; 79(1):44-9. PubMed ID: 9609461
[TBL] [Abstract][Full Text] [Related]
39. [A study of the association between HLA phenotype and serum concentration of soluble HLA class I].
Matsuura H; Jimbo S; Miyamura M; Katano M; Togashi K; Matsuda J
Nihon Rinsho Meneki Gakkai Kaishi; 1997 Apr; 20(2):102-7. PubMed ID: 9178967
[TBL] [Abstract][Full Text] [Related]
40. Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings.
Fainardi E; Rizzo R; Melchiorri L; Vaghi L; Castellazzi M; Marzola A; Govoni V; Paolino E; Tola MR; Granieri E; Baricordi OR
J Neuroimmunol; 2003 Sep; 142(1-2):149-58. PubMed ID: 14512174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
